Learn, Analyse & Invest
only with
only with
+91
Download Orca
Shakti Press Ltd.
Shakti Press
₹ 0.00
0.00 (0.00)%
NSE
BSE
Paper
Small-cap - With a market cap of ₹66.07 Cr.
| EX-Date | Purpose |
|---|---|
| 15 10 2022 | Quarterly Results |
| 29 05 2023 | Audited Results |
| 11 08 2023 | Quarterly Results |
| 10 11 2023 | Quarterly Results |
| 12 02 2024 | Quarterly Results |
| 14 11 2024 | Quarterly Results |
| 05 02 2025 | Quarterly Results |
| 26 05 2025 | Quarterly Results & Audited Results |
| 13 08 2025 | Quarterly Results |
| 30 08 2025 | Preferential Issue of shares & Inter alia, to consider and approve:- 1. To consider, approve and take on record the Notice of the annual general meeting for the financial year 2024-2025. 2. To appoint CS Adhishree Pimplapure, Practicing Company Secretary as the scrutinizer for voting to be held for the ensuing AGM to be held. 3. To appoint M/s Jain Paranjape & Associates as the secretarial auditors of the company from the conclusion of the ensuing annual general meeting till the conclusion of the 36th Annual General meeting of the company subject to the approval of the members at the AGM. 4. To consider and appoint Mr. Subrat Banerjee as the Executive Director of the company. 5. To consider and approve proposed preferential allotment of equity shares on private placement basis. |
| 11 11 2025 | Quarterly Results |
| 12 12 2025 | Rights Issue & Inter alia, to consider and approve:- To consider and evaluate the proposal for fund raising by way of issue of any instrument or securities through qualified institutional placement, private placement/ preferential issue of securities/Right issue or through any other permissible mode and/or combination thereof as may be considered appropriate, subject to such regulatory approvals as may be required including the approval of the members at a general meeting or through postal ballot and further subject to such statutory / regulatory approvals, as applicable. |
| 06 01 2026 | Rights Issue Inter alia, to transact with or without modification the following transactions: 1. To consider and evaluate the proposal for fund raising by way of issue of any instrument or securities through qualified institutional placement, private placement/ preferential issue of securities/Right issue or through any other permissible mode and/or combination thereof as may be considered appropriate, subject to such regulatory approvals as may be required including the approval of the members at a general meeting or through postal ballot and further subject to such statutory / regulatory approvals, as applicable. 2. Any other business matter with the permission of Chair. |
| 09 02 2026 | Quarterly Results |
| 13 02 2026 | Quarterly Results (Revised) The Board Meeting to be held on 09/02/2026 has been postponed to 13/02/2026 at 3:30 PM. |
| 25 02 2026 | Inter alia, to consider and approve:- 1. The brief term of Rights Issue including Equity shares to be offered through the issue, issue price per equity share, Right entitlement ratio, Terms of Payment, etc. 2. Record date, timing of the Rights Issue and other matters incidental or connected therewith. |
| 23 04 2026 | Rights Issue & Inter alia, to consider and approve:- 1. The brief term of Rights Issue including Equity shares to be offered through the issue, issue price per equity share, Right entitlement ratio, Terms of Payment, etc. 2. Record date, timing of the Rights Issue and other matters incidental or connected therewith. |
| 29 04 2026 | Rights Issue & Inter alia, to consider and approve:- 1. Approval of Letter of Offer 2. Approval of Abridged Letter of Offer along with Application Forms, Rights Entitlement Letter, and other related documents. |
News
No News data available
